Interestingly, previous studies have shown that EO771 tumors are dependent on IL-1β derived from the myeloid compartment in the tumor, which drives tumor progression, and that treatment with an IL-1 receptor antagonist inhibited tumor growth (24, 40). This evidence concerns the gene IL1B and neoplasm.